Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation.
A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues.
The integration was announced during the annual JP Morgan Health Care Conference in San Francisco. The program works through Amazon Benefits Manager to remotely help patients with weight and blood pressure management.
A new study concludes that in-office based imaging facilities fared better than hospital out-patient centers even after three years of steep cuts to in-office care under the Deficit Reduction Act.
The Alberta government in Canadian has called for a sweeping review of all diagnostic imaging and pathology tests in the province after multiple errors were found, which in several cases led to different diagnosis.
For treating patients with peripheral arterial disease (PAD), interventional radiologists cost Medicare less and resulted in better outcomes compared to other specialists.
GE Healthcare got a little more than it bargained for when it acquired Amersham Health Inc. in 2004. The company recently paid the federal government $30 million to settle allegations that Amersham violated the False Claims Act.
Vermont radiologists made their opinions known about a proposed 21% cut to Medicaid reimbursement, and the legislature lowered the reduction to just 2%.
Researchers at Johns Hopkins will begin searching for new ways to detect cancers in the earliest stages within cells using advanced imaging techniques.
Brain imaging techniques could be the most effective way to measure the progression of Huntington Disease, according to a study published this month in The Lancet.